Novartis has chosen Cambridge, MA as the location of its global vaccines and diagnostics division. The move will add 250 new employees to the 1,300 Novartis workers already employed at the company's Boston research division. Jorg Reinhardt, CEO of the Switzerland-based company, said Novartis was looking to capitalize on the thriving biotech cluster that has grown up around the Boston area. Massachusetts doesn't do much to compete for biotech relocations, but its reputation as a research hub and as a home to one of the world's most vibrant biotech clusters still wins plenty of new jobs for the area.
- read the report on Novartis from The Boston Globe